Novo’s Wegovy and Ozempic are among the most closely watched new medications in recent history, but face serious competition from Eli Lilly’s Zepbound and Mounjaro.

Experts are calling on the government to implement strategies that will better predict future Ozempic shortages.

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

Pharma giant Novo Nordisk, the company behind Wegovy and Ozempic, expects to launch six products in the next five years. Leading the pack of new drugs will be CagriSema.

Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine ...

CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

American host and television producer Oprah Winfrey recently shared her initial experience of taking the weight loss drug GLP ...

Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.

One in ten people in the UK have a needle phobia so serious it means they frequently miss out on vital treatments such as ...

Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...

As warnings are issued over weight loss medication being too easy to buy online, here is one cautionary tale of how it can be ...

Kanye West flaunted his toned figure at the 67th Grammy Awards, leading fans to speculate he has used the weight loss drug ...